Adrian Quartel is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Dec 2022: Acer Therapeutics Inc. (Newton, MA — biotechnology — 2022; $4.08M reported sold to 28 investors).
What this means One deal on file with the SEC, filed Dec 2022. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bernie Paul (1 shared filing), Chris Schelling (1 shared filing), Donald R. Joseph (1 shared filing), Harry S. Palmin (1 shared filing), Jason Amello (1 shared filing) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Adrian. Each name links to their own page.
The issuer belongs to the sponsor group Acer Therapeutics (2 issuers, $17.2M reported sold, 2009–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Acer Therapeutics has 2 companies on file and $17.2M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Adrian Quartel and found 1 difference: Adrian Quartel appears on 1 deal that stopped filing before reaching its target.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.